{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T18:39:39.009364+00:00","published_at":"2026-10-17T04:46:47.349247+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:ff0orr1ifvy1x","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:james-hunter","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"James Hunter seat on Tonix Pharmaceuticals Holding Corp., effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1afpq1e1l57dew","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:r-newcomb-stillwell","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"R. Newcomb Stillwell seat on Tonix Pharmaceuticals Holding Corp., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:vhlg0msrnoc0","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:tonix-pharmaceuticals-holding-corp:audit-nominating-and-governance","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Audit; Nominating and Governance committee of Tonix Pharmaceuticals Holding Corp., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qkz22fdccvgr","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:r-newcomb-stillwell","alpha:committee:tonix-pharmaceuticals-holding-corp:audit-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"R. Newcomb Stillwell member of Audit; Nominating and Governance, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fzzmeq1uuc9nk","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:carolyn-taylor","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Carolyn Taylor seat on Tonix Pharmaceuticals Holding Corp., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xme8zmya1998","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:richard-bagger","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Richard Bagger seat on Tonix Pharmaceuticals Holding Corp., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mj7wxc1j2scmg","event_type":"COMMITTEE_CREATED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:tonix-pharmaceuticals-holding-corp:audit-nominating-and-governance-chair","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Audit; Nominating and Governance · Chair committee of Tonix Pharmaceuticals Holding Corp., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:cjolzt18h91g7","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2020-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:richard-bagger","alpha:committee:tonix-pharmaceuticals-holding-corp:audit-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Richard Bagger member of Audit; Nominating and Governance · Chair, effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:e2cf8b1ctldg7","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:james-treco","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"James Treco seat on Tonix Pharmaceuticals Holding Corp., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9yc5h11th7awr","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:tonix-pharmaceuticals-holding-corp:audit-chair-nominating-and-governance","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Audit · Chair; Nominating and Governance committee of Tonix Pharmaceuticals Holding Corp., effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:7aehpu133uqzs","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:james-treco","alpha:committee:tonix-pharmaceuticals-holding-corp:audit-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"James Treco member of Audit · Chair; Nominating and Governance, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:dn4qbl19fm8sh","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:adeoye-olukotun","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Adeoye Olukotun seat on Tonix Pharmaceuticals Holding Corp., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:v1fp0h1gmpmor","event_type":"DIRECTOR_APPOINTED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:david-grange","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"David Grange seat on Tonix Pharmaceuticals Holding Corp., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ytasw1s2i315","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:adeoye-olukotun","alpha:committee:tonix-pharmaceuticals-holding-corp:compensation"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:committee_record:20"],"evidence_ids":["alpha:projection-evidence:6fd9f196d33a540cc3652fce4c0c1b63756702f7a24bf4275a02e1789bfb044a"],"summary":"Adeoye Olukotun member of Compensation, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hapzb51ynm1zn","event_type":"COMMITTEE_CREATED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:tonix-pharmaceuticals-holding-corp:compensation-nominating-and-governance","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Compensation; Nominating and Governance committee of Tonix Pharmaceuticals Holding Corp., effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:r34ogn1opyknx","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2018-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:david-grange","alpha:committee:tonix-pharmaceuticals-holding-corp:compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"David Grange member of Compensation; Nominating and Governance, effective 2018-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:uge73q13v5jj6","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:margaret-smith-bell","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Margaret Smith Bell seat on Tonix Pharmaceuticals Holding Corp., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1xxo7nm16pc94y","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:committee:tonix-pharmaceuticals-holding-corp:audit-compensation-chair","alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Audit; Compensation · Chair committee of Tonix Pharmaceuticals Holding Corp., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1s8elrqf7rh7y","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:46:47.349247+00:00","subject_ids":["alpha:person:margaret-smith-bell","alpha:committee:tonix-pharmaceuticals-holding-corp:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16"],"summary":"Margaret Smith Bell member of Audit; Compensation · Chair, effective 2017-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:7","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:adeoye-olukotun","object_label":"Adeoye Olukotun","object_source_name_forms":[],"value":"Adeoye Olukotun: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:adeoye-olukotun","name":"Adeoye Olukotun"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:8","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:carolyn-taylor","object_label":"Carolyn Taylor","object_source_name_forms":[],"value":"Carolyn Taylor: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:carolyn-taylor","name":"Carolyn Taylor"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:9","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-grange","object_label":"David Grange","object_source_name_forms":[],"value":"David Grange: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-grange","name":"David Grange"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:10","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-hunter","object_label":"James Hunter","object_source_name_forms":[],"value":"James Hunter: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-hunter","name":"James Hunter"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:11","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-treco","object_label":"James Treco","object_source_name_forms":[],"value":"James Treco: Director, Audit · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-treco","name":"James Treco"},"title":"Director","role_category":"director","committee":"Audit · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:12","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:margaret-smith-bell","object_label":"Margaret Smith Bell","object_source_name_forms":[],"value":"Margaret Smith Bell: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:margaret-smith-bell","name":"Margaret Smith Bell"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:13","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:r-newcomb-stillwell","object_label":"R. Newcomb Stillwell","object_source_name_forms":[],"value":"R. Newcomb Stillwell: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:r-newcomb-stillwell","name":"R. Newcomb Stillwell"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:leadership_role:14","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:richard-bagger","object_label":"Richard Bagger","object_source_name_forms":[],"value":"Richard Bagger: Director, Audit; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:richard-bagger","name":"Richard Bagger"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:4df4a796-0f65-480b-9eb0-22ab3da49017:committee_record:20","subject_id":"alpha:company:4df4a796-0f65-480b-9eb0-22ab3da49017","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Margaret Smith Bell; Members Margaret Smith Bell (Chair); Adeoye Olukotun; Carolyn Taylor; David Grange","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Margaret Smith Bell","members":[{"display_name":"Margaret Smith Bell","person_slug":"margaret-smith-bell","is_chair":true},{"display_name":"Adeoye Olukotun","person_slug":"adeoye-olukotun","is_chair":false},{"display_name":"Carolyn Taylor","person_slug":"carolyn-taylor","is_chair":false},{"display_name":"David Grange","person_slug":"david-grange","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:46:47.349247+00:00","sources":[{"id":"alpha:projection-evidence:6fd9f196d33a540cc3652fce4c0c1b63756702f7a24bf4275a02e1789bfb044a","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:32a71daabc96439d2e76b012c459018bed90446ef5ba2cb8c00d9487e6710c16","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Tonix Pharmaceuticals Holding Corp. DEF 14A 2026-03-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":"2026-03-30","retrieved_at":"2026-04-25T00:22:01.499+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:6fd9f196d33a540cc3652fce4c0c1b63756702f7a24bf4275a02e1789bfb044a","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126007108/tnxp-def14a_050726.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.825,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.866,"cross_source_agreement":0.75,"temporal_completeness":0.4},"diagnostics":{"published_claims":29,"factual_claims":29,"claims_with_linked_evidence":29,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":20,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:46:47.349247+00:00","observed_at":"2026-10-17T04:46:47.349247+00:00","reviewed_at":"2026-10-17T04:46:47.349247+00:00","verified_at":"2026-10-17T04:46:47.349247+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":29,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/tonix-pharmaceuticals-holding-corp/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/tonix-pharmaceuticals-holding-corp?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}